Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10059 |
| Vaccine Name | VLA2001 |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | Valneva |
| Year of Manufacturing | 2021 |
| Manufacturing Country | Austria |
| Age | 18 years and above |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intramuscular |
| Adjuvant | CpG 1018, aluminium hydroxide |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | EMA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT04864561 |
| Reference Link | https://clinicaltrials.gov/show/NCT04864561 |
| Additional Links | https://valneva.com/press-release/valneva-receives-marketing-authorization-in-europe-for-inactivated-whole-virus-covid-19-vaccine-vla2001/#:~:text=VLA2001%20is%20the%20only%20whole,to%2050%20years%20of%20age. |